US Regulatory Risks, Litigation Likely To Slow FY24 Growth For India’s Top Pharma Firms, Says ICRA

Pfizer Plant Damage Presents Opportunity

 
• By Vibha Ravi
  
Man Holding Up Falling Blocks
Will Companies In India Be Able To Ward Off Growth Challenges? • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip